Skip to main content
Top
Published in: Clinical Rheumatology 7/2012

01-07-2012 | Original Article

RETRACTED ARTICLE: Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire

Authors: Christian A. Waimann, Fernando M. Dal Pra, Maria F. Marengo, Emilce E. Schneeberger, Susana Gagliardi, Jose A. Maldonado Cocco, Mónica Sanchez, A. Garone, Rafael E. Chaparro del Moral, Oscar L. Rillo, Mariana Salcedo, Javier E. Rosa, F. Ceballos, Enrique R. Soriano, Gustavo Citera

Published in: Clinical Rheumatology | Issue 7/2012

Login to get access

Abstract

The Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire is the first needs-based instrument specifically designed to measure quality of life (QoL) of patients with rheumatoid arthritis (RA). The aims of our study were to develop an Argentinean version of the RAQoL and to determine its reproducibility, validity, and sensitivity to change in patients with RA. Translation process was performed according to internationally accepted methodology. Internal consistency and test–retest reliability were calculated. Criterion and construct validity were assessed by comparing the RAQoL with parameters of disease activity, the Health Assessment Questionnaire (HAQ), and the Medical Outcomes Study 36-item health survey (SF-36) questionnaire. Sensitivity to change was measured at 6–12 months using standardized response mean (SRM). The minimal important change was defined as a change of 1 or 1.96 times the standard error of measurement. A total of 97 patients with RA were included. Cronbach’s α was 0.93, and test–retest reliability was 0.95. The RAQoL showed moderate to strong correlation with parameters of disease activity, the HAQ, and the SF-36. Functional status was the main determinant of patients’ level of QoL. The SRM of the RAQoL was 0.24. Agreement between 20 % improvement in RAQoL and ACR20 response was moderate. Minimal important change was 2.2 (1 SEM) or 4.3 (1.96 SEM). The Argentinean version of the RAQoL is the first Spanish translation of this questionnaire. Our findings show it to be valid, reliable, and sensitive to changes in RA clinical status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaplan RM (2007) The future of outcomes measurement in rheumatology. Am J Manag Care 13(Suppl 9):S252–S255PubMed Kaplan RM (2007) The future of outcomes measurement in rheumatology. Am J Manag Care 13(Suppl 9):S252–S255PubMed
2.
go back to reference Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS (1976) The sickness impact profile: validation of a health status measure. Med Care 14(1):57–67PubMedCrossRef Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS (1976) The sickness impact profile: validation of a health status measure. Med Care 14(1):57–67PubMedCrossRef
3.
go back to reference Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM (2009) Argentine valuation of the EQ-5D health states. Value Health 12(4):587–596PubMedCrossRef Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM (2009) Argentine valuation of the EQ-5D health states. Value Health 12(4):587–596PubMedCrossRef
4.
go back to reference Houssien DA, McKenna SP, Scott DL (1997) The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36(1):69–73PubMedCrossRef Houssien DA, McKenna SP, Scott DL (1997) The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36(1):69–73PubMedCrossRef
5.
go back to reference Augustovski FA, Lewin G, Elorrio EG, Rubinstein A (2008) The Argentine–Spanish SF-36 Health Survey was successfully validated for local outcome research. J Clin Epidemiol 61(12):1279–1284PubMedCrossRef Augustovski FA, Lewin G, Elorrio EG, Rubinstein A (2008) The Argentine–Spanish SF-36 Health Survey was successfully validated for local outcome research. J Clin Epidemiol 61(12):1279–1284PubMedCrossRef
6.
go back to reference Pincus T, Wolfe F (2000) An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol 27(12):2727–2730PubMed Pincus T, Wolfe F (2000) An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol 27(12):2727–2730PubMed
7.
go back to reference Cooper JK, Kohlmann T, Michael JA, Haffer SC, Stevic M (2001) Health outcomes. New quality measure for Medicare. Int J Qual Health Care 13(1):9–16PubMedCrossRef Cooper JK, Kohlmann T, Michael JA, Haffer SC, Stevic M (2001) Health outcomes. New quality measure for Medicare. Int J Qual Health Care 13(1):9–16PubMedCrossRef
8.
go back to reference Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor M et al (1999) Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. J Rheumatol 26(1):217–221PubMed Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor M et al (1999) Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. J Rheumatol 26(1):217–221PubMed
9.
go back to reference Whalley D, McKenna SP, de Jong Z, van der Heijde D (1997) Quality of life in rheumatoid arthritis. Br J Rheumatol 36(8):884–888PubMedCrossRef Whalley D, McKenna SP, de Jong Z, van der Heijde D (1997) Quality of life in rheumatoid arthritis. Br J Rheumatol 36(8):884–888PubMedCrossRef
10.
go back to reference de Jong Z, van der Heijde D, McKenna SP, Whalley D (1997) The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 36(8):878–883PubMedCrossRef de Jong Z, van der Heijde D, McKenna SP, Whalley D (1997) The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 36(8):878–883PubMedCrossRef
11.
go back to reference McKenna SP, Hunt SM (1992) A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 22(3):321–330PubMedCrossRef McKenna SP, Hunt SM (1992) A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 22(3):321–330PubMedCrossRef
12.
go back to reference Cox SR, McWilliams L, Massy-Westropp N, Meads DM, McKenna SP, Proudman S (2007) Adaptation of the RAQoL for use in Australia. Rheumatol Int 27(7):661–666PubMedCrossRef Cox SR, McWilliams L, Massy-Westropp N, Meads DM, McKenna SP, Proudman S (2007) Adaptation of the RAQoL for use in Australia. Rheumatol Int 27(7):661–666PubMedCrossRef
13.
go back to reference Hedin PJ, McKenna SP, Meads DM (2006) The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation. Scand J Rheumatol 35(2):117–123PubMedCrossRef Hedin PJ, McKenna SP, Meads DM (2006) The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation. Scand J Rheumatol 35(2):117–123PubMedCrossRef
14.
go back to reference Bejia I, Salem KB, Touzi M, Bergaoui N. Validation of the Tunisian version of the rheumatoid arthritis quality of life (RAQoL) questionnaire. Clin Rheumatol. 2006. Bejia I, Salem KB, Touzi M, Bergaoui N. Validation of the Tunisian version of the rheumatoid arthritis quality of life (RAQoL) questionnaire. Clin Rheumatol. 2006.
15.
go back to reference Tammaru M, McKenna SP, Meads DM, Maimets K, Hansen E (2006) Adaptation of the rheumatoid arthritis quality of life scale for Estonia. Rheumatol Int 26(7):655–662PubMedCrossRef Tammaru M, McKenna SP, Meads DM, Maimets K, Hansen E (2006) Adaptation of the rheumatoid arthritis quality of life scale for Estonia. Rheumatol Int 26(7):655–662PubMedCrossRef
16.
go back to reference Tammaru M, Strompl J, Maimets K, Hanson E (2004) The value of the qualitative method for adaptation of a disease-specific quality of life assessment instrument: the case of the Rheumatoid Arthritis Quality of Life Scale (RAQoL) in Estonia. Health Qual Life Outcomes 2:69PubMedCrossRef Tammaru M, Strompl J, Maimets K, Hanson E (2004) The value of the qualitative method for adaptation of a disease-specific quality of life assessment instrument: the case of the Rheumatoid Arthritis Quality of Life Scale (RAQoL) in Estonia. Health Qual Life Outcomes 2:69PubMedCrossRef
17.
go back to reference Kutlay S, Kucukdeveci AA, Gonul D, Tennant A (2003) Adaptation and validation of the Turkish version of the Rheumatoid Arthritis Quality of Life Scale. Rheumatol Int 23(1):21–26PubMed Kutlay S, Kucukdeveci AA, Gonul D, Tennant A (2003) Adaptation and validation of the Turkish version of the Rheumatoid Arthritis Quality of Life Scale. Rheumatol Int 23(1):21–26PubMed
18.
go back to reference Eberhardt K, Duckberg S, Larsson BM, Johnson PM, Nived K (2002) Measuring health related quality of life in patients with rheumatoid arthritis—reliability, validity, and responsiveness of a Swedish version of RAQoL. Scand J Rheumatol 31(1):6–12PubMedCrossRef Eberhardt K, Duckberg S, Larsson BM, Johnson PM, Nived K (2002) Measuring health related quality of life in patients with rheumatoid arthritis—reliability, validity, and responsiveness of a Swedish version of RAQoL. Scand J Rheumatol 31(1):6–12PubMedCrossRef
19.
go back to reference Tijhuis GJ, de Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LM, Hazes JM et al (2001) The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford) 40(10):1112–1119CrossRef Tijhuis GJ, de Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LM, Hazes JM et al (2001) The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford) 40(10):1112–1119CrossRef
20.
go back to reference Neville C, Whalley D, McKenna S, Le Comte M, Fortin PR (2001) Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada. J Rheumatol 28(7):1505–1510PubMed Neville C, Whalley D, McKenna S, Le Comte M, Fortin PR (2001) Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada. J Rheumatol 28(7):1505–1510PubMed
21.
go back to reference Thorsen H, Hansen TM, McKenna SP, Sorensen SF, Whalley D (2001) Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Scand J Rheumatol 30(2):103–109PubMedCrossRef Thorsen H, Hansen TM, McKenna SP, Sorensen SF, Whalley D (2001) Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Scand J Rheumatol 30(2):103–109PubMedCrossRef
22.
go back to reference Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML (2008) Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 35(8):1528–1537PubMed Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML (2008) Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 35(8):1528–1537PubMed
23.
go back to reference Whalley D, McKenna S, Lovas K, Smedstad L, Fortin P (2000) International adaptation of the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Qual Life Res 9(3):342 Whalley D, McKenna S, Lovas K, Smedstad L, Fortin P (2000) International adaptation of the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Qual Life Res 9(3):342
24.
go back to reference Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM et al (2005) Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 14(5):1333–1344PubMedCrossRef Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM et al (2005) Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 14(5):1333–1344PubMedCrossRef
25.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef
26.
go back to reference Fuchs HA, Brooks RH, Callahan LF, Pincus T (1989) A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 32(5):531–537PubMedCrossRef Fuchs HA, Brooks RH, Callahan LF, Pincus T (1989) A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 32(5):531–537PubMedCrossRef
27.
go back to reference Citera G, Arriola MS, Maldonado-Cocco JA, Rosemffet MG, Sanchez MM, Goni MA et al (2004) Validation and crosscultural adaptation of an Argentine Spanish version of the health assessment questionnaire disability index. J Clin Rheumatol 10(3):110–115PubMedCrossRef Citera G, Arriola MS, Maldonado-Cocco JA, Rosemffet MG, Sanchez MM, Goni MA et al (2004) Validation and crosscultural adaptation of an Argentine Spanish version of the health assessment questionnaire disability index. J Clin Rheumatol 10(3):110–115PubMedCrossRef
28.
go back to reference van der Heijde D (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 27(1):261–263PubMed van der Heijde D (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 27(1):261–263PubMed
29.
go back to reference Streiner D, Norman G (2008) Health Measurement Scales: a practical guide to their development and use, 4th edn. Oxford University Press, New York Streiner D, Norman G (2008) Health Measurement Scales: a practical guide to their development and use, 4th edn. Oxford University Press, New York
30.
go back to reference Swaine-Verdier A, Doward LC, Hagell P, Thorsen H, McKenna SP (2004) Adapting quality of life instruments. Value Health 7(Suppl 1):S27–S30PubMedCrossRef Swaine-Verdier A, Doward LC, Hagell P, Thorsen H, McKenna SP (2004) Adapting quality of life instruments. Value Health 7(Suppl 1):S27–S30PubMedCrossRef
31.
go back to reference Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York
32.
go back to reference Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE et al (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60(7):1571–1582PubMedCrossRef Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE et al (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60(7):1571–1582PubMedCrossRef
33.
go back to reference Garip Y, Eser F, Bodur H (2010) Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int. Garip Y, Eser F, Bodur H (2010) Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int.
34.
go back to reference Liang MH (2000) Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care 38(9 Suppl):II84–II90PubMed Liang MH (2000) Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care 38(9 Suppl):II84–II90PubMed
35.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Laurence Erlbaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Laurence Erlbaum Associates, Hillsdale
36.
go back to reference Fransen J, van Riel PL (2009) Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther 11(5):244PubMedCrossRef Fransen J, van Riel PL (2009) Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther 11(5):244PubMedCrossRef
37.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174PubMedCrossRef
38.
go back to reference Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861–873PubMedCrossRef Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861–873PubMedCrossRef
39.
go back to reference McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307PubMedCrossRef McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307PubMedCrossRef
40.
go back to reference Wolfe F, Pincus T (1994) Rheumatoid arthritis: pathogenesis, assessment, outcome, and treatment. Dekker, New York Wolfe F, Pincus T (1994) Rheumatoid arthritis: pathogenesis, assessment, outcome, and treatment. Dekker, New York
41.
go back to reference Rasch G, Wright B (1993) Probabilistic models for some intelligence and attainment tests. MESA, Chicago Rasch G, Wright B (1993) Probabilistic models for some intelligence and attainment tests. MESA, Chicago
42.
go back to reference Pacheco-Tena C, Reyes-Cordero G, Mckenna SP et al (2011) Adaptation and validation of the Rheumatoid Arthritis Quality of Life Scale (RAQoL) to Mexican Spanish. Reumatol Clin 7(2):98–103PubMedCrossRef Pacheco-Tena C, Reyes-Cordero G, Mckenna SP et al (2011) Adaptation and validation of the Rheumatoid Arthritis Quality of Life Scale (RAQoL) to Mexican Spanish. Reumatol Clin 7(2):98–103PubMedCrossRef
Metadata
Title
RETRACTED ARTICLE: Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire
Authors
Christian A. Waimann
Fernando M. Dal Pra
Maria F. Marengo
Emilce E. Schneeberger
Susana Gagliardi
Jose A. Maldonado Cocco
Mónica Sanchez
A. Garone
Rafael E. Chaparro del Moral
Oscar L. Rillo
Mariana Salcedo
Javier E. Rosa
F. Ceballos
Enrique R. Soriano
Gustavo Citera
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-1976-6

Other articles of this Issue 7/2012

Clinical Rheumatology 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.